COM:SONNETBIO
Sonnet BioTherapeutics Holdings, Inc.
- Stock
Last Close
2.89
22/11 21:00
Market Cap
2.61M
Beta: -
Volume Today
45.44K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 304.22K - | 190.70K 37.31% | 363.31K 90.51% | 633.09K 74.25% | 500.15K 21.00% | 469.54K 6.12% | 239.16K 49.07% | |||||
average payables | 921.50K - | 1.95M 111.64% | 2.92M 49.69% | 4.27M 46.15% | 3.48M 18.51% | 2.19M 36.94% | ||||||
average receivables | 194.13K - | 113.59K 41.49% | 441.13K 288.35% | 703.37K 59.45% | 500.23K 28.88% | 431.61K 13.72% | 193.62K 55.14% | 393.29K - | 393.29K 0% | |||
book value per share | 2.57 - | 1.53 - | 0.58 62.08% | 4.24 632.14% | -7.45 275.67% | 4.49 160.25% | 12.70 182.88% | -0.58 104.60% | -0.22 62.72% | -0.74 240.57% | ||
capex per share | -0.13 - | -0.64 - | -6.26 873.04% | -0.11 98.19% | -0.00 98.17% | -0.21 9,877.93% | -0.43 107.08% | |||||
capex to depreciation | -0.76 - | -0.71 - | -1.11 55.32% | -1.31 18.13% | -0.04 97.09% | -9.61 25,149.51% | -5.85 39.13% | |||||
capex to operating cash flow | 0.34 - | 2.24 - | 1.08 52.08% | 0.00 99.55% | 0.00 96.71% | 0.03 20,054.89% | 0.02 35.86% | |||||
capex to revenue | -0.04 - | -0.04 - | -0.06 50.18% | -0.01 - | -2.56 34,096.62% | -3.00 17.06% | ||||||
cash per share | 0.10 - | 0.11 - | 0.01 88.46% | 0.11 773.28% | 0.09 13.67% | 10.92 11,603.59% | 15.75 44.23% | 0.70 95.54% | 2.19 212.00% | 0.23 89.59% | ||
days of inventory on hand | 18.90 - | 14.71 22.17% | 12.28 16.48% | 22.01 79.18% | ||||||||
days payables outstanding | 84.79 - | |||||||||||
days sales outstanding | 4.74 - | 7.60 - | 4.59 39.56% | 4.19 8.66% | 3.48 17.00% | 1.94K - | ||||||
debt to assets | 0.07 - | 0.22 - | 0.30 37.17% | 0.30 2.18% | 80.93 27,180.92% | 0.04 99.95% | 0.00 90.17% | 0.04 911.34% | 0.04 14.47% | 0.05 25.75% | ||
debt to equity | 0.12 - | 0.43 - | 0.81 88.46% | 0.84 3.47% | -1.13 235.20% | 0.12 110.35% | 0.01 95.17% | -0.10 1,883.08% | -0.90 794.88% | -0.27 70.14% | ||
dividend yield | ||||||||||||
earnings yield | -0.00 - | -0.00 - | -0.00 16.92% | -0.00 927.16% | -0.00 1,688.79% | -0.06 2,451.50% | -0.08 30.17% | -0.21 178.94% | -6.32 2,885.10% | -1.70 73.16% | ||
enterprise value | 1.88T - | 1.14T - | 729.69B 36.04% | 53.19B 92.71% | 2.20B 95.86% | 525.64M 76.14% | 301.93M 42.56% | 137.82M 54.35% | 909.25K 99.34% | 4.36M 380.06% | ||
enterprise value over ebitda | -323.90K - | -84.95K - | -78.63K 7.44% | -8.23K 89.53% | -467.85 94.32% | -49.89 89.34% | -12.09 75.76% | -4.65 61.51% | -0.05 98.95% | -0.37 656.66% | ||
ev to operating cash flow | -212.70K - | -73.42K - | -989.70 98.65% | -33.66 96.60% | -13.39 60.23% | -4.98 62.82% | -0.04 99.14% | -0.51 1,090.26% | ||||
ev to sales | 107.29K - | 26.91K - | 17.50K 34.97% | 1.28K 92.66% | 54.24 95.78% | 624.30 - | 393.84 36.91% | 6.15 98.44% | 234.35 3,709.48% | |||
free cash flow per share | -0.50 - | -0.93 - | -12.09 1,199.12% | -23.32 92.87% | -12.86 44.83% | -6.57 48.90% | -20.98 219.21% | -13.14 37.40% | ||||
free cash flow yield | -0.00 - | -0.00 - | -0.00 4,645.40% | -0.03 1,304.91% | -0.07 132.42% | -0.20 196.87% | -7.31 3,496.90% | -1.96 73.14% | ||||
graham net net | -1.84 - | -1.26 - | -0.87 30.84% | -7.06 712.90% | -6.07 14.01% | 3.53 158.13% | 11.91 237.47% | -1.22 110.26% | -2.69 119.92% | -4.74 76.38% | ||
graham number | 8.89 - | 5.41 - | 2.33 56.85% | 16.02 586.23% | 46.99 193.30% | 68.27 45.28% | 63.83 6.51% | 9.48 85.14% | 9.43 0.62% | 13.76 45.98% | ||
income quality | 0.37 - | 0.10 - | 0.46 351.99% | 0.64 40.84% | 0.90 40.27% | 0.93 3.20% | 1.13 21.65% | 1.16 2.13% | ||||
intangibles to total assets | 0.49 - | 0 100% | 0.47 Infinity% | 0.57 19.43% | 0.61 8.65% | 412.63 67,059.22% | 0 100% | 0 | 0 | 0 | 0 | |
interest coverage | 3.31 - | 1.12 66.28% | 2.02 80.88% | 1.86 7.74% | -1.17K 63,024.90% | 727.64 - | ||||||
interest debt per share | 0.31 - | 0.41 - | 0.36 12.52% | 2.52 599.94% | 1.81 28.31% | 0.56 69.23% | 0.07 87.08% | 0.05 31.06% | 0.20 296.83% | 0.20 1.68% | ||
inventory turnover | 19.32 - | 24.82 28.49% | 29.72 19.73% | 16.59 44.19% | ||||||||
invested capital | 0.12 - | 0.43 - | 0.81 88.46% | 0.84 3.47% | -1.13 235.20% | 0.12 110.35% | 0.01 95.17% | -0.10 1,883.08% | -0.90 794.88% | -948.31K 105,094,657.88% | ||
market cap | 1.88T - | 1.14T - | 729.68B 36.04% | 53.18B 92.71% | 2.20B 95.86% | 532.63M 75.82% | 329.42M 38.15% | 140.62M 57.31% | 2.98M 97.88% | 4.38M 47.12% | ||
net current asset value | -7.14M - | -16.63M - | -17.99M 8.17% | -16.89M 6.08% | -2.85M 83.16% | 2.66M 193.59% | 22.08M 729.00% | -2.95M 113.38% | -917.23K 68.96% | -1.14M 24.16% | ||
net debt to ebitda | -0.16 - | -0.58 - | -1.07 83.35% | -1.34 26.13% | -0.04 97.13% | 0.66 1,820.41% | 1.10 65.83% | 0.09 91.42% | 0.11 17.38% | 0.00 98.58% | ||
net income per share | -1.37 - | -0.85 - | -0.42 50.89% | -2.69 543.20% | -13.18 389.71% | -46.16 250.29% | -14.26 69.10% | -6.85 51.99% | -18.14 164.91% | -11.35 37.43% | ||
operating cash flow per share | -0.38 - | -0.29 - | -5.83 1,930.76% | -23.21 298.29% | -12.86 44.57% | -6.37 50.49% | -20.56 222.84% | -13.14 36.10% | ||||
payables turnover | 4.30 - | |||||||||||
receivables turnover | 77.02 - | 48.05 - | 79.51 65.46% | 87.05 9.48% | 104.88 20.49% | 0.19 - | ||||||
research and ddevelopement to revenue | 0.05 - | 34.40 - | 61.28 78.16% | 79.93 30.44% | 308.02 285.35% | |||||||
return on tangible assets | -0.59 - | -0.55 - | -0.62 14.22% | -0.58 6.41% | 0.31 152.69% | -3.89 1,362.96% | -0.86 77.80% | -5.11 492.15% | -3.47 32.08% | -2.68 22.62% | ||
revenue per share | 4.01 - | 2.98 - | 1.92 35.41% | 16.41 753.65% | 106.31 547.91% | 0.28 - | 0.08 70.82% | 0.14 76.90% | 0.03 80.03% | |||
roe | -0.53 - | -0.56 - | -0.72 29.50% | -0.63 12.15% | 1.77 378.76% | -10.29 681.37% | -1.12 89.08% | 11.73 1,144.01% | 83.34 610.58% | 15.31 81.63% | ||
roic | -0.46 - | -0.36 - | -0.11 69.88% | -0.29 162.76% | -13.08 4,438.91% | -8.67 33.77% | -1.12 87.13% | 14.66 1,414.22% | -103.57 806.48% | |||
sales general and administrative to revenue | 0.17 - | 0.14 20.47% | 0.11 21.13% | 0.06 43.69% | 18.48 - | 24.50 32.62% | 48.21 96.74% | 329.16 582.75% | ||||
shareholders equity per share | 2.57 - | 1.53 - | 0.58 62.08% | 4.24 632.14% | -7.45 275.67% | 4.49 160.25% | 12.70 182.88% | -0.58 104.60% | -0.22 62.72% | -0.74 240.57% | ||
stock based compensation to revenue | -0.01 - | -0.03 - | -0.04 35.82% | 2.84 - | 2.50 11.94% | 1.68 32.83% | 12.41 637.89% | |||||
tangible asset value | 1.32M - | 1.77M - | -5.23M 395.06% | -7.06M 34.88% | -19.25M 172.82% | 3.02M 115.69% | 22.26M 637.10% | -2.54M 111.40% | -225.98K 91.10% | -485.74K 114.95% | ||
tangible book value per share | 0.30 - | 0.12 - | -0.24 293.74% | -2.79 1,058.86% | -50.39 1,703.28% | 4.49 108.91% | 12.70 182.88% | -0.58 104.60% | -0.22 62.72% | -0.74 240.57% | ||
working capital | -3.82M - | -12.36M - | -10.32M 16.54% | -13.11M 27.03% | -2.85M 78.29% | 2.91M 202.38% | 22.11M 658.91% | -2.75M 112.44% | -786.37K 71.41% | -1.09M 38.90% |
All numbers in USD (except ratios and percentages)